HARMONY is an ambitious program, with a clear goal to optimise care for patients suffering from Hematologic Malignancies. By actively involving all the relevant representatives of the Healtcare System and applying Big Data Technologies, innovative therapies will be developed and provided in a sustainable manner. We trust we will make a difference for the patient, as the HARMONY Alliance has the means for its ambition!
Read more about this initiative >>
Receive the latest news. Click here to subscribe!
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
